XS-03

Other Medications

1 Clinical Trials

Description

XS-03 is an investigational medication currently being studied by NovaOnco Therapeutics Co., Ltd. It is being evaluated in clinical trials for people with metastatic colorectal cancer (CRC). Specifically, it is being tested in combination with standard chemotherapy regimens (FOLFOX or FOLFIRI) and bevacizumab. The trials are focusing on patients whose tumors have a RAS mutation. XS-03 is in Phase 1 trials, which means it is being tested for the first time in humans to determine the best way to give it, find the right dose, and see how safe it is. It is not yet approved for use in CRC or any other condition.

Mechanism of Action

The specific way XS-03 works (its mechanism of action) is still being investigated in clinical trials. It is being studied to see if it can help improve the effectiveness of standard treatments for metastatic colorectal cancer, particularly in patients with RAS mutations. The exact molecular target or pathway it affects is not yet fully defined.

Side Effects

Because XS-03 is an investigational drug in early-phase trials (Phase 1) The full range of potential side effects is still being evaluated. Side effects observed in the current trials are being carefully monitored to assess safety and determine the appropriate dosage. More information about side effects will become available as clinical trials progress.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT06936527 Phase 1
Enrolling by invitation
XS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Patients With RAS Mutation
China

Quick Info

CategoryOther Medications
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
787 trials
Leucovorin
Other Medications
648 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.